Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergopharma GmbH & Co. KG
The rationale for the present study was to demonstrate clinical efficacy and tolerability compared to placebo in a phase III clinical study of pivotal character with a representative number of patients suffering from fully reversible asthma +/- allergic rhinitis. This condition is present in paediatric and adult patients with a shorter history of GINA II and III asthma, who were investigated in this study.
Age
6–40
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Bronchial asthma
Requirements for inhaled corticosteroid
Positive skin prick test to house dust mite
Positive radioallergosorbent test (RAST) to house dust mite
Positive provocation test result to house dust mite
You may not be if
Serious chronic diseases
Other perennial allergies
Clareo Health | Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
